Erratum: IL-12 gene-modified bone marrow cell therapy suppresses the development of experimental metastatic prostate cancer (Cancer Gene Therapy (2001) 14, (819-827) DOI: 10.1038/sj.cgt.7701069)

H. Wang, G. Yang, T. L. Timme, T. Fujita, K. Naruishi, A. Frolov, M. K. Brenner, D. Kadmon, T. C. Thompson

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)873-874
Number of pages2
JournalCancer Gene Therapy
Volume14
Issue number10
DOIs
StatePublished - Oct 2007

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Cancer Research

Cite this